(Q33230192)

24 July 2017

title

3-O-sulfated oligosaccharide structures are recognized by anti-heparan sulfate antibody HS4C3. (English)

1 reference

24 July 2017

1 reference

1 reference

5

0 references

Dorothe Spillmann

6

0 references

author name string

Gerdy B Ten Dam

1

1 reference

24 July 2017

Sindhulakshmi Kurup

2

1 reference

24 July 2017

Els M A van de Westerlo

3

1 reference

24 July 2017

Elly M M Versteeg

4

1 reference

24 July 2017

Toin H van Kuppevelt

7

1 reference

24 July 2017

language of work or name

English

0 references

publication date

22 December 2005

1 reference

Journal of Biological Chemistry

24 July 2017

published in

1 reference

24 July 2017

volume

281

1 reference

24 July 2017

issue

8

1 reference

24 July 2017

page(s)

4654-4662

1 reference

Molecular diversity of heparan sulfate

24 July 2017

cites work

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M506357200

Structure and biological interactions of heparin and heparan sulfate

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M506357200

Functions of cell surface heparan sulfate proteoglycans

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M506357200

Order out of chaos: assembly of ligand binding sites in heparan sulfate

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M506357200

Sulfotransferases in glycosaminoglycan biosynthesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M506357200

QSulf1 remodels the 6-O sulfation states of cell surface heparan sulfate proteoglycans to promote Wnt signaling

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M506357200

Abnormal mast cells in mice deficient in a heparin-synthesizing enzyme

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M506357200

The occurrence of three isoforms of heparan sulfate 6-O-sulfotransferase having different specificities for hexuronic acid adjacent to the targeted N-sulfoglucosamine

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M506357200

Normal levels of anticoagulant heparan sulfate are not essential for normal hemostasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M506357200

Role of heparan sulfate-2-O-sulfotransferase in the mouse.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M506357200

Defective heparan sulfate biosynthesis and neonatal lethality in mice lacking N-deacetylase/N-sulfotransferase-1

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M506357200

Targeted disruption of a murine glucuronyl C5-epimerase gene results in heparan sulfate lacking L-iduronic acid and in neonatal lethality

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M506357200

1976-1983, a critical period in the history of heparin: the discovery of the antithrombin binding site

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M506357200

A role for 3-O-sulfated heparan sulfate in cell fusion induced by herpes simplex virus type 1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M506357200

Heparan sulfate 3-O-sulfotransferase isoform 5 generates both an antithrombin-binding site and an entry receptor for herpes simplex virus, type 1

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M506357200

A specific structural alteration in the heparan sulphate of human glomerular basement membrane in diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M506357200

Methylation-associated silencing of heparan sulfate D-glucosaminyl 3-O-sulfotransferase-2 (3-OST-2) in human breast, colon, lung and pancreatic cancers

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M506357200

Different affinities of glycosaminoglycan oligosaccharides for monomeric and dimeric interleukin-8: a model for chemokine regulation at inflammatory sites

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M506357200

Differential effects of heparin saccharides on the formation of specific fibroblast growth factor (FGF) and FGF receptor complexes

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M506357200

Generation and application of type-specific anti-heparan sulfate antibodies using phage display technology. Further evidence for heparan sulfate heterogeneity in the kidney

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M506357200

Human single chain antibodies against heparin: selection, characterization, and effect on coagulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M506357200

Differential Expression of Heparan Sulfate Domains in Rat Spleen

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M506357200

Defining the interleukin-8-binding domain of heparan sulfate

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M506357200

Formation of anhydrosugars in the chemical depolymerization of heparin

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M506357200

Biosynthesis of heparin. Use of Escherichia coli K5 capsular polysaccharide as a model substrate in enzymic polymer-modification reactions

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M506357200

Structural requirement of heparan sulfate for interaction with herpes simplex virus type 1 virions and isolated glycoprotein C.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M506357200

Structure of the antithrombin-binding site in heparin

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M506357200

A strategy for rapid sequencing of heparan sulfate and heparin saccharides

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M506357200

Detection of 2-O-sulfated iduronate and N-acetylglucosamine units in heparan sulfate by an antibody selected against acharan sulfate (IdoA2S-GlcNAc)n

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M506357200

Developmental changes in heparan sulfate expression: in situ detection with mAbs

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M506357200

Oligosaccharide Library-based Assessment of Heparan Sulfate 6-O-Sulfotransferase Substrate Specificity

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M506357200

Glycosaminoglycans and the regulation of blood coagulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M506357200

Heterogeneity of heparan sulfates in human lung

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M506357200

Domain structure of heparan sulfates from bovine organs

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M506357200

Molecular cloning and expression of mouse and human cDNAs encoding heparan sulfate D-glucosaminyl 3-O-sulfotransferase

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M506357200

Multiple isoforms of heparan sulfate D-glucosaminyl 3-O-sulfotransferase. Isolation, characterization, and expression of human cdnas and identification of distinct genomic loci

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M506357200

Heparan sulfate D-glucosaminyl 3-O-sulfotransferase-3A sulfates N-unsubstituted glucosamine residues

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M506357200

Biosynthesis of 3-O-sulfated heparan sulfate: unique substrate specificity of heparan sulfate 3-O-sulfotransferase isoform 5.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M506357200

Purification of heparan sulfate D-glucosaminyl 3-O-sulfotransferase

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M506357200

6-O-sulfotransferase-1 represents a critical enzyme in the anticoagulant heparan sulfate biosynthetic pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M506357200

The biosynthesis of anticoagulant heparan sulfate by the heparan sulfate 3-O-sulfotransferase isoform 5.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M506357200

Presence of N-unsubstituted glucosamine units in native heparan sulfate revealed by a monoclonal antibody.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M506357200

Novel heparan sulfate structures revealed by monoclonal antibodies

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M506357200

Characterization of growth factor-binding structures in heparin/heparan sulfate using an octasaccharide library

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M506357200

Biosynthetic oligosaccharide libraries for identification of protein-binding heparan sulfate motifs. Exploring the structural diversity by screening for fibroblast growth factor (FGF)1 and FGF2 binding

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M506357200

Sequence analysis of heparan sulfate epitopes with graded affinities for fibroblast growth factors 1 and 2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M506357200

Role of heparan sulfate domain organization in endostatin inhibition of endothelial cell function

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M506357200

Binding of heparin/heparan sulfate to fibroblast growth factor receptor 4.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M506357200

Large, tissue-regulated domain diversity of heparan sulfates demonstrated by phage display antibodies

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M506357200

21 January 2018

Identifiers

DOI

10.1074/JBC.M506357200

1 reference

24 July 2017

1 reference